Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]

View source ↗

Summary

This completed study evaluated whether Antareit 800 mg chewable tablets are pharmacodynamically equivalent to Riopan 800 mg chewable tablets in healthy voluntee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Heartburn
• Peptic Ulcer Disease

Drugs mentioned

• Antareit 800 mg chewable tablets (Antareit)
• Riopan 800 mg chewable tablets (Riopan)

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract | NA | Status: COMPLETED